Let's take a look at the stocks that are in motion in today's session. Keep an eye on the top gainers and losers in Thursday's session, as they reflect the most notable price movements.
Which stocks are experiencing notable movement on Thursday? Stay up-to-date with the latest market trends in the middle of the day on Thursday. Explore the top gainers and losers during today's session in our detailed report.
Thursday's session: gap up and gap down stocks Let's have a look at what is happening on the US markets on Thursday. Below you can find the gap up and gap down stocks in today's session.
Ultragenyx, Mereo Shares Dive As Brittle Bone Disease Drug Misses Early Win Ultragenyx shares fall after Phase 3 study misses interim target, but analysts remain positive ahead of final OI data expected later this year.
Get insights into the top gainers and losers of Thursday's pre-market session. Before the US market kicks off on Thursday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers.
What's going on in today's after hours session Let's have a look at what is happening on the US markets after the closing bell on Wednesday. Below you can find the top gainers and losers in today's after hours session.
Analyst Bullish On Ultragenyx, Poised For Growth With Six Drug Approvals Expected By 2028 Ultragenyx sees rising revenue and analyst support as key drug launch approaches, with potential profitability projected for 2027.
Ultragenyx Stays On JPMorgan's Focus List As Analyst Highlights Strong Long-Term Positioning JP Morgan sees strong upside for Ultragenyx, citing setrusumab trial progress and pipeline growth, raising the price target to $117.
